Allspring Global Investments Holdings, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022
SELL
$144.95 - $152.29 $90.4 Million - $95 Million
-623,542 Reduced 68.45%
287,350 $43.4 Million
Q2 2022

Jul 25, 2022
SELL
$83.14 - $145.99 $115 Million - $202 Million
-1,382,951 Reduced 60.29%
910,892 $133 Million
Q1 2022

May 02, 2022
BUY
$110.08 - $142.92 $83.3 Million - $108 Million
756,363 Added 49.19%
2,293,843 $272 Million
Q4 2021

Jan 28, 2022
BUY
$99.73 - $148.48 $153 Million - $228 Million
1,537,480 New
1,537,480 $212 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email